The study “A Pharmacokinetic Framework Describing Antibiotic Adsorption to Cardiopulmonary Bypass Devices” by Conor J. O’Hanlon et al. explores how cardiopulmonary bypass (CPB) can significantly alter the pharmacokinetic (PK) parameters of antibiotics, potentially leading to therapeutic failures. Cefazolin, a commonly used beta-lactam antibiotic for antimicrobial prophylaxis during cardiac surgery with CPB, may adsorb to the…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest